StreetInsider.com News Articles

Form ARS GALECTIN THERAPEUTICS For: Dec 31

Tue, 13 Oct 2026 08:01:00 -0400

si-local-file:///var/storage/secattach/20261013/27177504.html

Form DEFA14A GALECTIN THERAPEUTICS

Tue, 13 Oct 2026 08:01:00 -0400

si-local-file:///var/storage/secattach/20261013/27177497.html

Form DEF 14A GALECTIN THERAPEUTICS For: Dec 03

Tue, 13 Oct 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20261013/27177439.html

Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026

Tue, 06 Oct 2026 08:00:00 -0400

NORCROSS, Ga., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced participation in the upcoming AASLD Liver Meeting 2026. The Company will deliver three presentations, including an oral presentation, a Poster of Distinction presentation, and one poster presentation, highlighting new risk analyses on noninvasive prediction of variceal development from the NAVIGATE and GT-026 Phase 2b trials of belapectin for the treatment of MASH cirrhosis and portal hypertension. The meeting will be held November 5-9, 2026, in Denver, Colorado.

In addition,

Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026

Tue, 06 Oct 2026 08:00:00 -0400

In addition,

Form PRE 14A GALECTIN THERAPEUTICS For: Dec 03

Fri, 02 Oct 2026 15:54:00 -0400

si-local-file:///var/storage/secattach/20261002/27141897.html

Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Thu, 10 Sep 2026 08:00:00 -0400

NORCROSS, Ga., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that company management will present and attend the H.C. Wainwright 28th Annual Global Investment Conference, taking place September 14-16, 2026 in New York, NY.

Presentation details:
Format: Company presentation and 1 on 1 meetings
Date & time: September 14th, 2026, at 11:30 AM ET
Webcast: https://journey.ct.events/view/c18a40de-8b48-4807-b323-6fd60b6d73a8

The Galectin management team will be available for one-on-one meetings during the conference. Interested investors should contact their representative at H.C. Wainwright.

The

Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Thu, 10 Sep 2026 08:00:00 -0400

The Galectin management team will be available for one-on-one meetings during the conference. Interested investors should contact their representative at H.C. Wainwright.

The

Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update